ClinicalTrials.govpublic full text
Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
chronic lymphocytic leukemia, cll, cytokine signaling, signal transduction inhibitors, elderly, p53, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838170
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.